Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 5(17), p. 326-327
DOI: 10.1016/j.clml.2016.12.005
Links
Tools
More About the Risk of Ibrutinib-associated Bleeding
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 